A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients With Germ Cell Tumors

6987AGCT1531-NCT03067181OpenA Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients With Germ Cell TumorsAGCT1531NCT03067181NationalBothTreatmentIIIGlobalIll-Defined SitesPudela, CaileighLombardi Comprehensive Cancer Center : Richik ChakrabortyPediatricsOncology GroupLombardi Comprehensive Cancer Center (LCCC); NCA MU NCORP15940Richik ChakrabortyRichik Chakrabortyrc1586@georgetown.edu2026.1.0 Build 16 <a href="https://advarra.com" target="_blank">© 2026 Advarra, Inc.</a>